Here’s how our Neurological Institute is working to counter national trends of burnout and leadership inequity among women in medicine, with a focus on the role psychologists can play in such efforts.Read More
The Essentials on Esketamine for Treatment-Resistant Depression
The newly approved intranasal ketamine derivative helps fill clear gaps in short-term therapy, says one expert, but questions remain around its long-term effects and affordability.
Advice on Creating a Healthcare Safe Haven for LGBTQ Youth
Making clear that your practice is a safe space for LGBTQ youth is a huge first step toward easing the anxieties of teens needing care as they struggle with sexual identity issues.
When Bariatric Surgery Comes Up Short: Probing the Behavioral-Biological Reasons
Cleveland Clinic is co-directing a newly launched NIH clinical trial that aims to better understand — and potentially target — the mind and body factors behind suboptimal bariatric surgery outcomes.
Ketamine vs. ECT: $11.8M Grant Helps Size Them Up for Treatment-Resistant Depression
Ketamine has emerged as an alternative to electroconvulsive therapy for treatment-resistant depression, but no study has compared the two. A major research project led by Cleveland Clinic is changing that.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Deep Brain Stimulation for Neuropsych Disorders: Don’t Count It Out Yet
An expert panel at Cleveland Clinic’s Medical Innovation Summit explores lessons from the failed controlled trials of DBS for depression — and the striking reasons for continued interest in this approach.